Abstract
Background: Large-scale radiographic datasets often include errors in labels such as body–part or projection, which can undermine automated image analysis. Purpose: To develop and externally validate two deep learning models—one for categorizing radiographs by body-part, and another for identifying projection and rotation of chest radiographs—using large, diverse datasets. Methods: We retrospectively collected radiographs from multiple institutions and public repositories. For the first model (Xp-Bodypart-Checker), we included seven categories (Head, Neck, Chest, Incomplete Chest, Abdomen, Pelvis, Extremities). For the second model (CXp-Projection-Rotation-Checker), we classified chest radiographs by projection (anterior-posterior, posterior-anterior, lateral) and rotation (upright, inverted, 90° left, 90° right). Both models were trained, tuned, and internally tested on separate data, then externally tested on radiographs from different institutions. Model performance was assessed using overall accuracy (macro, micro, and weighted) as well as area under the curve (one-vs-all). Results: In the Xp-Bodypart-Checker development phase, we included 429,341 radiographs obtained from Institutions A, B, and MURA. In the CXp-Projection-Rotation-Checker development phase, we included 463,728 chest radiographs from CheXpert, PadChest, and Institution A. The Xp-Bodypart-Checker achieved AUC values of 1.00 (99% CI: 1.00 – 1.00) for all classes other than Incomplete Chest, which had an AUC value of 0.99 (99% CI: 0.98 – 1.00). The CXp-Projection-Rotation-Checker demonstrated AUC values of 1.00 (99% CI: 1.00 – 1.00) across all projection and rotation classifications. Conclusion: These models help automatically verify image labels in large radiographic databases, improving quality control across multiple institutions.
Competing Interest Statement
This work was supported by JST BOOST, Japan Grant Number JPMJBS2401 and the Japan Society for the Promotion of Science (JSPS) KAKENHI (24K18804).
Funding Statement
This work was funded by JST BOOST, Japan Grant Number JPMJBS2401 and the Japan Society for the Promotion of Science (JSPS) KAKENHI (24K18804).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Osaka Metropolitan University gave ethical approval for this work (approval numbers 43, 2024-100, and 2022-0021K).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.